This article is more than 5 years old. Information may no longer be current.
Focused Ultrasound Foundation, Cancer Research Institute partner to advance immunotherapy research
Click Here to Manage Email Alerts
Focused Ultrasound Foundation and Cancer Research Institute will partner to advance the research and development of new focused ultrasound and cancer immunotherapy treatments.
“This partnership formalizes a long-standing relationship between Cancer Research Institute and the Focused Ultrasound Foundation,” Jill O’Donnell-Tormey, PhD, CEO and director of scientific affairs at Cancer Research Institute, said in a press release. “We have previously co-sponsored workshops, promoted awareness of opportunities in this field, and co-funded research. Our goal at Cancer Research Institute is to accelerate the field of cancer immunotherapy, and we believe that focused ultrasound is a valuable tool that could increase efficacy.”
Through the partnership, the organizations will establish a joint fund to support research into new combination therapies. A panel of expert advisors will determine critical unanswered research questions regarding immunotherapy treatment.
In turn, a request for applications will be issued to encourage future research addressing these identified knowledge gaps.
After review and assessment, the organizations will share the costs to fund the chosen research projects. Cancer Research Institute will administer grants on behalf of the joint program.
“We are incredibly excited about this partnership,” Jessica Foley, PhD, chief scientific officer of Focused Ultrasound Foundation, said in the release. “Drawing on the expertise of our two organizations and our diverse research communities, we expect to advance more streamlined and rigorous research that will enable quicker progress toward clinical trials, while also enabling better standardization in the field and increased consistency of protocols.”